FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 184 filers reported holding FIBROGEN INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $149,101 | -76.9% | 55,223 | +11.4% | 0.00% | -80.0% |
| Q3 2022 | $645,000 | -53.3% | 49,579 | +24.6% | 0.01% | -70.6% |
| Q1 2021 | $1,382,000 | -58.1% | 39,801 | -44.2% | 0.02% | -86.6% |
| Q4 2018 | $3,299,000 | +399.8% | 71,300 | +77.2% | 0.13% | -14.2% |
| Q2 2016 | $660,000 | – | 40,236 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |